{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:05:28Z","timestamp":1791461128663,"version":"4.3.4"},"reference-count":221,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.colsurfb.2025.115204","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T04:56:23Z","timestamp":1760504183000},"page":"115204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Revolutionizing cancer treatment: Nanotherapeutics targeting the tumor micro-environment"],"prefix":"10.1016","volume":"258","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7576-1627","authenticated-orcid":false,"given":"Deepak Chandra","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2202-3639","authenticated-orcid":false,"given":"Sonima","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Bhati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravesh Kumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmal","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2073-3290","authenticated-orcid":false,"given":"Sumit","family":"Durgapal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuri Bapu","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishesh Kumar","family":"Maurya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vetriselvan","family":"Subramaniyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3591-2080","authenticated-orcid":false,"given":"Keshav Raj","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.colsurfb.2025.115204_bib1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41571-021-00514-z","article-title":"Planning for tomorrow: global cancer incidence and the role of prevention 2020\u20132070","volume":"18","author":"Soerjomataram","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.colsurfb.2025.115204_bib2","series-title":"in Bioprospecting of Tropical Medicinal Plants","first-page":"1429","article-title":"The global concern for cancer emergence and its prevention: a systematic unveiling of the present scenario","author":"Ghufran","year":"2023"},{"key":"10.1016\/j.colsurfb.2025.115204_bib3","series-title":"In Nanoparticles in Cancer Theranostics","first-page":"173","article-title":"Conventional methods of cancer therapy","author":"Chambial","year":"2024"},{"key":"10.1016\/j.colsurfb.2025.115204_bib4","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10555-013-9447-3","article-title":"Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch","volume":"32","author":"Baldo","year":"2013","journal-title":"Cancer Metastas.. Rev."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s11671-023-03913-6","article-title":"An updated landscape on nanotechnology-based drug delivery, immunotherapy, vaccinations, imaging, and biomarker detections for cancers: recent trends and future directions with clinical success","volume":"18","author":"Kumbhar","year":"2023","journal-title":"Discov. Nano"},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115204_bib6","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3109\/10717544.2015.1092183","article-title":"Lipid-based nanocarriers for breast cancer treatment\u2013comprehensive review","volume":"23","author":"Talluri","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.colsurfb.2025.115204_bib7","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2147\/IJN.S488961","article-title":"Advancements in liposomal nanomedicines: innovative formulations, therapeutic applications, and future directions in precision Medicine","author":"Izadiyan","year":"2025","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"10.1016\/j.colsurfb.2025.115204_bib8","first-page":"395","article-title":"Nanooncology: the future of cancer diagnosis and therapy","volume":"63","author":"Thakor","year":"2013","journal-title":"CA a cancer journal clinicians"},{"issue":"2","key":"10.1016\/j.colsurfb.2025.115204_bib9","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.3390\/molecules20022728","article-title":"The multifaceted role of curcumin in cancer prevention and treatment","volume":"20","author":"Shanmugam","year":"2015","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.colsurfb.2025.115204_bib10","first-page":"328","article-title":"Fight against cancer in countries with limited resources: the post-genomic era scenario","volume":"5","author":"Pal","year":"2004","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"11","key":"10.1016\/j.colsurfb.2025.115204_bib11","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1007\/s11033-023-08809-3","article-title":"Cancer treatment therapies: traditional to modern approaches to combat cancers","volume":"50","author":"Kaur","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41936-019-0083-5","article-title":"Recent advances in radiotherapy and its associated side effects in cancer\u2014a review","volume":"80","author":"Mohan","year":"2019","journal-title":"J. Basic Appl. Zool."},{"key":"10.1016\/j.colsurfb.2025.115204_bib13","series-title":"In Nanomedicine","first-page":"179","article-title":"Nanomedicine in targeted drug delivery: precision therapeutics for personalized Medicine","author":"Dey","year":"2024"},{"issue":"2","key":"10.1016\/j.colsurfb.2025.115204_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.15171\/bi.2017.15","article-title":"Molecular machineries of ph dysregulation in TME: potential targets for cancer therapy","volume":"7","author":"Asgharzadeh","year":"2017","journal-title":"BioImpacts BI"},{"issue":"22","key":"10.1016\/j.colsurfb.2025.115204_bib15","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1039\/C6CS00458J","article-title":"Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy","volume":"45","author":"Liang","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.colsurfb.2025.115204_bib16","article-title":"Cuproptosis engineered nanomaterials: the silent warrior against cancer","volume":"39","author":"Dongsar","year":"2024","journal-title":"Appl. Mater. Today"},{"issue":"5","key":"10.1016\/j.colsurfb.2025.115204_bib17","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1021\/acs.chemrev.5b00148","article-title":"Nanochemistry and nanomedicine for nanoparticle-based diagnostics and therapy","volume":"116","author":"Chen","year":"2016","journal-title":"Chem. Rev."},{"issue":"7","key":"10.1016\/j.colsurfb.2025.115204_bib18","doi-asserted-by":"crossref","first-page":"9994","DOI":"10.1021\/acsnano.2c00128","article-title":"Where is nano today and where is it headed? A review of nanomedicine and the dilemma of nanotoxicology","volume":"16","author":"Domingues","year":"2022","journal-title":"ACS nano"},{"key":"10.1016\/j.colsurfb.2025.115204_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.52711\/2321-5836.2022.00002","article-title":"Review on radiation therapy on cancer","author":"Dhakad","year":"2022","journal-title":"Res. J. Pharmacol. Pharmacodyn."},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115204_bib20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrc.2016.18","article-title":"Radiation oncology in the era of precision Medicine","volume":"16","author":"Baumann","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.colsurfb.2025.115204_bib21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.addr.2013.09.007","article-title":"Molecular imaging for cancer diagnosis and surgery","volume":"66","author":"Hussain","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.colsurfb.2025.115204_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s42979-021-00815-1","article-title":"Deep learning: a comprehensive overview on techniques, taxonomy, applications and research directions","volume":"2","author":"Sarker","year":"2021","journal-title":"SN Comput. Sci."},{"issue":"17","key":"10.1016\/j.colsurfb.2025.115204_bib23","doi-asserted-by":"crossref","first-page":"9118","DOI":"10.3390\/ijms22179118","article-title":"Targeted delivery of drugs and genes using polymer nanocarriers for cancer therapy","volume":"22","author":"Xia","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2025.115204_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.597634","article-title":"External and internal stimuli-responsive metallic nanotherapeutics for enhanced anticancer therapy","volume":"7","author":"Mohapatra","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"6","key":"10.1016\/j.colsurfb.2025.115204_bib25","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/17425247.2024.2370492","article-title":"Metabolism and structure of PDA as the target for new therapies: possibilities and limitations for nanotechnology","volume":"21","author":"Zygmunt","year":"2024","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.colsurfb.2025.115204_bib26","article-title":"Interplay between solid tumors and TME","volume":"13","author":"Kim","year":"2022","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.colsurfb.2025.115204_bib27","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1517\/17425247.2015.1071791","article-title":"Applications of nanoparticles in cancer Medicine and beyond: optical and multimodal in vivo imaging, tissue targeting and drug delivery","volume":"12","author":"Biffi","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"issue":"2","key":"10.1016\/j.colsurfb.2025.115204_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2010.08.027","article-title":"To exploit the TME: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery","volume":"148","author":"Danhier","year":"2010","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.colsurfb.2025.115204_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/smsc.202400113","article-title":"The advent of molecular targeted therapies against cancer. Toward Multi-Targeting drugs through materials engineering: a possible future scenario","volume":"4","author":"Puzzo","year":"2024","journal-title":"Small Sci."},{"issue":"28","key":"10.1016\/j.colsurfb.2025.115204_bib30","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1002\/adma.201200446","article-title":"Engineering nano-and microparticles to tune immunity","volume":"24","author":"Moon","year":"2012","journal-title":"Adv. Mater."},{"issue":"25","key":"10.1016\/j.colsurfb.2025.115204_bib31","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1038\/onc.2014.291","article-title":"Cancer systems biology: embracing complexity to develop better anticancer therapeutic strategies","volume":"34","author":"Du","year":"2015","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.colsurfb.2025.115204_bib32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3390\/cancers13030525","article-title":"The adhesome network: key components shaping the tumour stroma","volume":"13","author":"Nikolopoulou","year":"2021","journal-title":"Cancers"},{"issue":"23","key":"10.1016\/j.colsurfb.2025.115204_bib33","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.3390\/cancers13236135","article-title":"TME features and chemoresistance in pancreatic ductal adenocarcinoma: insights into targeting physicochemical barriers and metabolism as therapeutic approaches","volume":"13","author":"Carvalho","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.colsurfb.2025.115204_bib34","series-title":"in Cytokine and Chemokine Networks in Cancer","first-page":"33","article-title":"Cytokines and chemokines in tumor growth and progression","author":"Mir","year":"2023"},{"key":"10.1016\/j.colsurfb.2025.115204_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2017.04.005","article-title":"Tumor promoting role of anti-tumor macrophages in TME","volume":"316","author":"Goswami","year":"2017","journal-title":"Cell. Immunol."},{"issue":"7","key":"10.1016\/j.colsurfb.2025.115204_bib36","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.3390\/ijms18071586","article-title":"The role of TME in chemoresistance: to survive, keep your enemies closer","volume":"18","author":"Senthebane","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.colsurfb.2025.115204_bib37","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41571-018-0007-1","article-title":"Targeting the tumour stroma to improve cancer therapy","volume":"15","author":"Valkenburg","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib38","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1034\/j.1600-065X.2003.00076.x","article-title":"A stochastic view of lymphocyte motility and trafficking within the lymph node","volume":"195","author":"Wei","year":"2003","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.colsurfb.2025.115204_bib39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fonc.2017.00068","article-title":"Metabolic cooperation and competition in the TME: implications for therapy","volume":"7","author":"Gupta","year":"2017","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s42255-020-00317-z","article-title":"Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism","volume":"3","author":"Elia","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.colsurfb.2025.115204_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.656364","article-title":"Aspects of the TME involved in immune resistance and drug resistance","volume":"12","author":"Khalaf","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.colsurfb.2025.115204_bib42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fonc.2015.00165","article-title":"Overview of methods for overcoming hindrance to drug delivery to tumors, with special attention to tumor interstitial fluid","volume":"5","author":"Baronzio","year":"2015","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.colsurfb.2025.115204_bib43","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.ymthe.2005.07.693","article-title":"Contribution of bone marrow-derived cells to blood vessels in ischemic tissues and tumors","volume":"12","author":"Aghi","year":"2005","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","article-title":"Macrophages and metabolism in the TME","volume":"30","author":"Vitale","year":"2019","journal-title":"Cell Metab."},{"issue":"13","key":"10.1016\/j.colsurfb.2025.115204_bib45","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.3390\/jcm10132788","article-title":"Myeloid-derived suppressor cells and mesenchymal stem\/stromal cells in myeloid malignancies","volume":"10","author":"Kapor","year":"2021","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115204_bib46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00418-023-02258-6","article-title":"From complexity to clarity: unravelling tumor heterogeneity through the lens of TME for innovative cancer therapy","volume":"161","author":"Imodoye","year":"2024","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.colsurfb.2025.115204_bib47","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.biomaterials.2017.10.024","article-title":"Overcoming obstacles in the TME: recent advancements in nanoparticle delivery for cancer theranostics","volume":"156","author":"Overchuk","year":"2018","journal-title":"Biomaterials"},{"issue":"17","key":"10.1016\/j.colsurfb.2025.115204_bib48","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.3390\/cancers13174444","article-title":"Normalizing tumor vasculature to reduce hypoxia, enhance perfusion, and optimize therapy uptake","volume":"13","author":"Matuszewska","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.colsurfb.2025.115204_bib49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/HP.S133231","article-title":"A review of the development of tumor vasculature and its effects on the TME","author":"Forster","year":"2017","journal-title":"Hypoxia"},{"issue":"7","key":"10.1016\/j.colsurfb.2025.115204_bib50","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.3390\/jcm12072648","article-title":"Organic nanodelivery systems as a new platform in the management of breast cancer: a comprehensive review from preclinical to clinical studies","volume":"12","author":"Rafik","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.colsurfb.2025.115204_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20230037","article-title":"Deformable nanocarriers for enhanced drug delivery and cancer therapy","author":"Cao","year":"2024","journal-title":"Exploration"},{"issue":"9","key":"10.1016\/j.colsurfb.2025.115204_bib52","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41578-021-00315-x","article-title":"Multifunctional biomolecule nanostructures for cancer therapy","volume":"6","author":"Wang","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.colsurfb.2025.115204_bib53","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2147\/DDDT.S441325","article-title":"Exploring the frontier of Biopolymer-Assisted drug delivery: advancements, clinical applications, and future perspectives in cancer nanomedicine","author":"Alharbi","year":"2024","journal-title":"Drug Des. Dev. Ther."},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115204_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e26351","article-title":"Recent progresses in natural based therapeutic materials for alzheimer's disease","volume":"10","author":"Zivari-Ghader","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.colsurfb.2025.115204_bib55","first-page":"37","article-title":"Targeted drug delivery systems in oncology: a review of recent patents and future directions","author":"Kumar","year":"2025","journal-title":"Int. J. Health Sci. Eng."},{"issue":"11","key":"10.1016\/j.colsurfb.2025.115204_bib56","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.3390\/pharmaceutics15112623","article-title":"Translational challenges and prospective solutions in the implementation of biomimetic delivery systems","volume":"15","author":"Wang","year":"2023","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.colsurfb.2025.115204_bib57","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.3390\/pharmaceutics14101990","article-title":"Nanoparticle-based drug delivery systems targeting TME for cancer immunotherapy resistance: current advances and applications","volume":"14","author":"Wu","year":"2022","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115204_bib58","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3390\/pharmaceutics14040866","article-title":"Emerging nanotherapeutic approaches to overcome drug resistance in cancers with update on clinical trials","volume":"14","author":"Bukhari","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2025.115204_bib59","first-page":"589","article-title":"Overview of the role of nanotechnological innovations in the detection and treatment of solid tumors","author":"Frank","year":"2014","journal-title":"Int. J. Nanomed."},{"issue":"9","key":"10.1016\/j.colsurfb.2025.115204_bib60","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1021\/acs.bioconjchem.9b00456","article-title":"Insights into active targeting of nanoparticles in drug delivery: advances in clinical studies and design considerations for cancer nanomedicine","volume":"30","author":"Pearce","year":"2019","journal-title":"Bioconjugate Chem."},{"issue":"6","key":"10.1016\/j.colsurfb.2025.115204_bib61","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3390\/ijms20061263","article-title":"Nano-strategies to target breast cancer-associated fibroblasts: rearranging the TME to achieve antitumor efficacy","volume":"20","author":"Truffi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2025.115204_bib62","series-title":"in Understanding cancer","first-page":"217","article-title":"Chemotherapy and radiation therapy for cancer","author":"Mathan","year":"2022"},{"issue":"11","key":"10.1016\/j.colsurfb.2025.115204_bib63","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.3390\/molecules26113382","article-title":"A review on cancer immunotherapy and applications of nanotechnology to chemoimmunotherapy of different cancers","volume":"26","author":"Akk\u0131n","year":"2021","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115204_bib64","first-page":"309","article-title":"TME and nanotherapeutics","volume":"2","author":"Upreti","year":"2013","journal-title":"Transl. Cancer Res."},{"issue":"2-3","key":"10.1016\/j.colsurfb.2025.115204_bib65","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1383-5742(02)00046-7","article-title":"Genetic and environmental factors in cancer and neurodegenerative diseases","volume":"512","author":"Migliore","year":"2002","journal-title":"Mutat. Res. \/Rev. Mutat. Res."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib66","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/1120009X.2023.2300224","article-title":"The TME: shaping cancer progression and treatment response","volume":"37","author":"Desai","year":"2025","journal-title":"J. Chemother."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib67","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-017-0004-3","article-title":"Controlled drug delivery vehicles for cancer treatment and their performance","volume":"3","author":"Senapati","year":"2018","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib68","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41392-023-01462-z","article-title":"Radiation-induced tumor immune microenvironments and potential targets for combination therapy","volume":"8","author":"Guo","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.colsurfb.2025.115204_bib69","doi-asserted-by":"crossref","DOI":"10.1039\/D3NR06131K","article-title":"Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy","author":"Sandbhor","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.colsurfb.2025.115204_bib70","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fmolb.2019.00160","article-title":"Extracellular matrix in the TME and its impact on cancer therapy","volume":"6","author":"Henke","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.colsurfb.2025.115204_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-018-0792-2","article-title":"Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors","volume":"17","author":"Montor","year":"2018","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.colsurfb.2025.115204_bib72","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ejps.2012.12.006","article-title":"A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics","volume":"48","author":"Steichen","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.colsurfb.2025.115204_bib73","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/jphp.13098","article-title":"An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites","volume":"71","author":"Attia","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.colsurfb.2025.115204_bib74","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1208\/s12248-012-9339-4","article-title":"Challenges in development of nanoparticle-based therapeutics","volume":"14","author":"Desai","year":"2012","journal-title":"AAPS J."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib75","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jps.23773","article-title":"Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems","volume":"103","author":"Kraft","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115204_bib76","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3390\/cancers13040670","article-title":"Recent advancements in stimuli responsive drug delivery platforms for active and passive cancer targeting","volume":"13","author":"Rahim","year":"2021","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.colsurfb.2025.115204_bib77","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nrc.2017.93","article-title":"Transport of drugs from blood vessels to tumour tissue","volume":"17","author":"Dewhirst","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.colsurfb.2025.115204_bib78","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2014.12.030","article-title":"Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications","volume":"200","author":"Wicki","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2025.115204_bib79","series-title":"in Natural polymers for drug delivery","first-page":"53","article-title":"Polymer-based nanoparticles for drug delivery systems and cancer therapeutics","author":"Ram Prasad","year":"2017"},{"issue":"2","key":"10.1016\/j.colsurfb.2025.115204_bib80","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.progpolymsci.2011.06.004","article-title":"Biodegradable synthetic polymers: preparation, functionalization and biomedical application","volume":"37","author":"Tian","year":"2012","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.colsurfb.2025.115204_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2021.214393","article-title":"Polymer-metal-organic framework hybrids for bioimaging and cancer therapy","volume":"456","author":"Fu","year":"2022","journal-title":"Coord. Chem. Rev."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib82","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40824-016-0081-3","article-title":"Lipid-based surface engineering of PLGA nanoparticles for drug and gene delivery applications","volume":"20","author":"Bose","year":"2016","journal-title":"Biomater. Res."},{"issue":"3","key":"10.1016\/j.colsurfb.2025.115204_bib83","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.3390\/cancers3033279","article-title":"Assessment of the evolution of cancer treatment therapies","volume":"3","author":"Arruebo","year":"2011","journal-title":"Cancers"},{"issue":"24","key":"10.1016\/j.colsurfb.2025.115204_bib84","doi-asserted-by":"crossref","first-page":"8038","DOI":"10.3390\/molecules28248038","article-title":"The bioavailability of drugs\u2014the current state of knowledge","volume":"28","author":"Stielow","year":"2023","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.colsurfb.2025.115204_bib85","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3390\/ijms19061549","article-title":"Approaches in polymeric nanoparticles for vaginal drug delivery: a review of the state of the art","volume":"19","author":"Leyva-G\u00f3mez","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2025.115204_bib86","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.addr.2015.12.002","article-title":"Delivery of cancer therapeutics to extracellular and intracellular targets: determinants, barriers, challenges and opportunities","volume":"97","author":"Au","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.colsurfb.2025.115204_bib87","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/cancers9120173","article-title":"Recent advances in cancer therapy based on dual mode gold nanoparticles","volume":"9","author":"Spyratou","year":"2017","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib88","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijrobp.2013.02.021","article-title":"Image guided radiation therapy (IGRT) technologies for radiation therapy localization and delivery","volume":"87","author":"De Los Santos","year":"2013","journal-title":"Int. J. Radiat. Oncol. * Biol. * Phys."},{"key":"10.1016\/j.colsurfb.2025.115204_bib89","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.2147\/IJN.S398254","article-title":"Albumin-modified gold nanoparticles as novel radiosensitizers for enhancing lung cancer radiotherapy","author":"Chen","year":"2023","journal-title":"Int. J. Nanomed."},{"issue":"9","key":"10.1016\/j.colsurfb.2025.115204_bib90","doi-asserted-by":"crossref","first-page":"7979","DOI":"10.1021\/acsnano.3c00891","article-title":"Photodynamic and photothermal therapies: synergy opportunities for nanomedicine","volume":"17","author":"Overchuk","year":"2023","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.colsurfb.2025.115204_bib91","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1039\/D1BM01963E","article-title":"Superparamagnetic iron oxide nanoparticles for magnetic hyperthermia: recent advancements, molecular effects, and future directions in the omics era","volume":"10","author":"Pucci","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.colsurfb.2025.115204_bib92","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10555-013-9441-9","article-title":"Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review","volume":"32","author":"Azmi","year":"2013","journal-title":"Cancer Metastas.. Rev."},{"key":"10.1016\/j.colsurfb.2025.115204_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103628","article-title":"New advances in exosome-based targeted drug delivery systems","volume":"172","author":"Ferreira","year":"2022","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib94","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1021\/acsnano.9b04224","article-title":"Present and future of surface-enhanced Raman scattering","volume":"14","author":"Langer","year":"2019","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115204_bib95","doi-asserted-by":"crossref","first-page":"138","DOI":"10.31254\/jsir.2016.5408","article-title":"Effect of niosomes in the transdermal delivery of antidepressant sertraline hydrochloride","volume":"5","author":"Rajendran","year":"2016","journal-title":"J. Sci. Innov. Res."},{"issue":"6","key":"10.1016\/j.colsurfb.2025.115204_bib96","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.3390\/cancers14061435","article-title":"Exosomes as emerging drug delivery and diagnostic modality for breast cancer: recent advances in isolation and application","volume":"14","author":"Kumar","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib97","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12943-022-01650-5","article-title":"Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential","volume":"21","author":"Lin","year":"2022","journal-title":"Mol. Cancer"},{"issue":"19","key":"10.1016\/j.colsurfb.2025.115204_bib98","doi-asserted-by":"crossref","first-page":"7022","DOI":"10.3390\/ijms21197022","article-title":"Exosome composition and seminal plasma proteome: a promising source of biomarkers of Male infertility","volume":"21","author":"Candenas","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib99","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41392-023-01366-y","article-title":"Molecular and functional imaging in cancer-targeted therapy: current applications and future directions","volume":"8","author":"Bai","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"20","key":"10.1016\/j.colsurfb.2025.115204_bib100","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.3390\/molecules25204831","article-title":"Targeting metabolism in cancer cells and the tumour microenvironment for cancer therapy","volume":"25","author":"Li","year":"2020","journal-title":"Molecules"},{"issue":"23","key":"10.1016\/j.colsurfb.2025.115204_bib101","doi-asserted-by":"crossref","first-page":"10475","DOI":"10.1021\/acs.jmedchem.9b00511","article-title":"Precision cancer nanotherapy: evolving role of multifunctional nanoparticles for cancer active targeting","volume":"62","author":"Ahmad","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.colsurfb.2025.115204_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-015-0278-7","article-title":"New horizons in TME biology: challenges and opportunities","volume":"13","author":"Chen","year":"2015","journal-title":"BMC Med."},{"issue":"9","key":"10.1016\/j.colsurfb.2025.115204_bib103","doi-asserted-by":"crossref","first-page":"22094","DOI":"10.3390\/ijms160922094","article-title":"Drug carrier for photodynamic cancer therapy","volume":"16","author":"Debele","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2025.115204_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2022.100134","article-title":"Nano-based drug delivery systems: conventional drug delivery routes, recent developments and future prospects","volume":"15","author":"Sultana","year":"2022","journal-title":"Med. Drug Discov."},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115204_bib105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41578-020-00269-6","article-title":"Targeted drug delivery strategies for precision medicines","volume":"6","author":"Manzari","year":"2021","journal-title":"Nat. Rev. Mater."},{"issue":"8","key":"10.1016\/j.colsurfb.2025.115204_bib106","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/pharmaceutics16081076","article-title":"Recent review on biological barriers and host\u2013material interfaces in precision drug delivery: advancement in biomaterial engineering for better treatment therapies","volume":"16","author":"Deshmukh","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2025.115204_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113305","article-title":"Recent advancements of nanoparticles application in cancer and neurodegenerative disorders: at a glance","volume":"153","author":"Rahman","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.colsurfb.2025.115204_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112737","article-title":"Liposomes containing nanoparticles: preparation and applications","volume":"218","author":"De Leo","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"3","key":"10.1016\/j.colsurfb.2025.115204_bib109","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3390\/ph16030433","article-title":"Exploring the application of micellar drug delivery systems in cancer nanomedicine","volume":"16","author":"Wang","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.colsurfb.2025.115204_bib110","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.nano.2015.10.018","article-title":"Advances in silica based nanoparticles for targeted cancer therapy","volume":"12","author":"Yang","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"2","key":"10.1016\/j.colsurfb.2025.115204_bib111","doi-asserted-by":"crossref","DOI":"10.1002\/lpor.202300565","article-title":"X-ray excited luminescence materials for cancer diagnosis and theranostics","volume":"18","author":"Ma","year":"2024","journal-title":"Laser Photonics Rev."},{"issue":"8","key":"10.1016\/j.colsurfb.2025.115204_bib112","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.3390\/cancers16081589","article-title":"Targeted nanoparticle-based diagnostic and treatment options for pancreatic cancer","volume":"16","author":"Gu","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.colsurfb.2025.115204_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2022.100083","article-title":"Overcoming challenges to enable targeting of metastatic breast cancer tumour microenvironment with nano-therapeutics: current status and future perspectives","volume":"8","author":"Niveria","year":"2022","journal-title":"OpenNano"},{"key":"10.1016\/j.colsurfb.2025.115204_bib114","doi-asserted-by":"crossref","first-page":"132","DOI":"10.18433\/jpps30583","article-title":"Targeted nanomedicines for cancer therapy, from basics to clinical trials","volume":"23","author":"Eskandari","year":"2020","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115204_bib115","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3390\/ijms20040840","article-title":"Targeting TME for cancer therapy","volume":"20","author":"Roma-Rodrigues","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.colsurfb.2025.115204_bib116","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/jpm11030229","article-title":"The 35th anniversary of the discovery of EPR effect: a new wave of nanomedicines for tumor-targeted drug delivery\u2014personal remarks and future prospects","volume":"11","author":"Maeda","year":"2021","journal-title":"J. Pers. Med."},{"issue":"5","key":"10.1016\/j.colsurfb.2025.115204_bib117","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3109\/14756366.2014.966704","article-title":"Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium","volume":"30","author":"Pettersen","year":"2015","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.colsurfb.2025.115204_bib118","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.623760","article-title":"Triggered drug release from liposomes: exploiting the outer and inner tumor environment","volume":"11","author":"Franco","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.colsurfb.2025.115204_bib119","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.2147\/IJN.S210116","article-title":"Smart nanomedicine agents for cancer, triggered by ph, glutathione, H2O2, or H2S","author":"Li","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115204_bib120","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jpha.2018.07.002","article-title":"Analytical methods for investigating in vivo fate of nanoliposomes: a review","volume":"8","author":"Su","year":"2018","journal-title":"J. Pharm. Anal."},{"issue":"36","key":"10.1016\/j.colsurfb.2025.115204_bib121","doi-asserted-by":"crossref","first-page":"23568","DOI":"10.1021\/acsami.6b08239","article-title":"TME and angiogenic blood vessels dual-targeting for enhanced anti-glioma therapy","volume":"8","author":"Hu","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.colsurfb.2025.115204_bib122","first-page":"1537","article-title":"Receptor binding peptides for target-selective delivery of nanoparticles encapsulated drugs","author":"Accardo","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2025.115204_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2016.10.033","article-title":"Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer","volume":"113","author":"Yao","year":"2017","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115204_bib124","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.7150\/thno.39995","article-title":"Towards extracellular matrix normalization for improved treatment of solid tumors","volume":"10","author":"Abyaneh","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.colsurfb.2025.115204_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.139938","article-title":"Triterpenoids and ultrasound dual-catalytic nanoreactor ignites long-lived hypertoxic reactive species storm for deep tumor treatment","volume":"453","author":"Li","year":"2023","journal-title":"Chem. Eng. J."},{"issue":"43","key":"10.1016\/j.colsurfb.2025.115204_bib126","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201907308","article-title":"Redox-responsive nanobiomaterials-based therapeutics for neurodegenerative diseases","volume":"16","author":"Eleftheriadou","year":"2020","journal-title":"Small"},{"issue":"2","key":"10.1016\/j.colsurfb.2025.115204_bib127","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/pharmaceutics17020142","article-title":"Emerging approaches in glioblastoma treatment: modulating the extracellular matrix through nanotechnology","volume":"17","author":"Horta","year":"2025","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.colsurfb.2025.115204_bib128","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11051-024-06074-4","article-title":"Drug delivery systems for tissue engineering: exploring novel strategies for enhanced regeneration","volume":"26","author":"de Oliveira","year":"2024","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.colsurfb.2025.115204_bib129","series-title":"A theoretical investigation of oxygen carriers to relieve tissue hypoxia in cancer therapy","author":"Bush","year":"2021"},{"key":"10.1016\/j.colsurfb.2025.115204_bib130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the TME","volume":"18","author":"Jing","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.colsurfb.2025.115204_bib131","series-title":"in Prostate Cancer: Advancements in the Pathogenesis, Diagnosis and Personalized Therapy","first-page":"43","article-title":"Basic insights into TME in prostate cancer","author":"Mijatovi\u0107","year":"2024"},{"key":"10.1016\/j.colsurfb.2025.115204_bib132","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s10555-014-9506-4","article-title":"Extracellular acidity, a \u201creappreciated\u201d trait of tumor environment driving malignancy: perspectives in diagnosis and therapy","volume":"33","author":"Peppicelli","year":"2014","journal-title":"Cancer Metastas.. Rev."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib133","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s43556-024-00239-2","article-title":"Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer","volume":"6","author":"Gu","year":"2025","journal-title":"Mol. Biomed."},{"issue":"5","key":"10.1016\/j.colsurfb.2025.115204_bib134","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","article-title":"Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis","volume":"23","author":"Hicklin","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib135","first-page":"13","article-title":"Vascular endothelial growth factor and ocular neovascularization","volume":"151","author":"Miller","year":"1997","journal-title":"Am. J. Pathol."},{"issue":"5-6","key":"10.1016\/j.colsurfb.2025.115204_bib136","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000534440","article-title":"Current management of subretinal hemorrhage in neovascular age-related macular degeneration","volume":"246","author":"Oncel","year":"2023","journal-title":"Ophthalmologica"},{"issue":"9","key":"10.1016\/j.colsurfb.2025.115204_bib137","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3390\/cells8091102","article-title":"Trends and challenges in tumor anti-angiogenic therapies","volume":"8","author":"J\u00e1szai","year":"2019","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.colsurfb.2025.115204_bib138","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/nrneph.2015.15","article-title":"Renal effects of targeted anticancer therapies","volume":"11","author":"Porta","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.colsurfb.2025.115204_bib139","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10456-017-9577-2","article-title":"Bone marrow sinusoidal endothelium: damage and potential regeneration following cancer radiotherapy or chemotherapy","volume":"20","author":"Hassanshahi","year":"2017","journal-title":"Angiogenesis"},{"issue":"7","key":"10.1016\/j.colsurfb.2025.115204_bib140","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1021\/cr8005125","article-title":"Molecular regulation of tumor angiogenesis and perfusion via redox signaling","volume":"109","author":"Miller","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.colsurfb.2025.115204_bib141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(06)90001-7","article-title":"Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity","volume":"90","author":"Smyth","year":"2006","journal-title":"Adv. Immunol."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib142","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41392-021-00506-6","article-title":"Targeting macrophages in cancer immunotherapy","volume":"6","author":"Duan","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.colsurfb.2025.115204_bib143","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/cancers6031670","article-title":"Tumor-associated macrophages as major players in the TME","volume":"6","author":"Chanmee","year":"2014","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.colsurfb.2025.115204_bib144","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/cancers13020210","article-title":"The functional crosstalk between myeloid-derived suppressor cells and regulatory t cells within the immunosuppressive TME","volume":"13","author":"Haist","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115204_bib145","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41423-020-00556-w","article-title":"Implications of metabolism-driven myeloid dysfunctions in cancer therapy","volume":"18","author":"Strauss","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.colsurfb.2025.115204_bib146","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.3389\/fimmu.2018.03176","article-title":"Human dendritic cells: their heterogeneity and clinical application potential in cancer immunotherapy","volume":"9","author":"Patente","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.colsurfb.2025.115204_bib147","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fcell.2019.00207","article-title":"Epigenetic therapies for acute myeloid leukemia and their immune-related effects","volume":"7","author":"Gambacorta","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115204_bib148","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1158\/0008-5472.CAN-19-1457","article-title":"The diagnostic, prognostic, and therapeutic potential of adaptive immune receptor repertoire profiling in cancer","volume":"80","author":"Cowell","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.colsurfb.2025.115204_bib149","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.biomaterials.2016.10.016","article-title":"Drug self-delivery systems for cancer therapy","volume":"112","author":"Qin","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2025.115204_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114449","article-title":"Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms","volume":"188","author":"Zi","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.colsurfb.2025.115204_bib151","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.4c09566","article-title":"Transforming Medicine: Cutting-Edge applications of nanoscale materials in drug delivery","author":"Tenchov","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.colsurfb.2025.115204_bib152","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3389\/fphar.2018.01230","article-title":"TME targeted nanotherapy","volume":"9","author":"Fernandes","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.colsurfb.2025.115204_bib153","article-title":"Navigating the future of cancer management through carbon nanodots: a review","volume":"39","author":"Malhan","year":"2024","journal-title":"NanoStruct. NanoObjects"},{"issue":"5","key":"10.1016\/j.colsurfb.2025.115204_bib154","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3390\/pharmaceutics14051113","article-title":"Functionalization of nanoparticulate drug delivery systems and its influence in cancer therapy","volume":"14","author":"Seidu","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2025.115204_bib155","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cca.2014.05.004","article-title":"Targeted anticancer therapy: overexpressed receptors and nanotechnology","volume":"436","author":"Akhtar","year":"2014","journal-title":"Clin. Chim. Acta"},{"issue":"6","key":"10.1016\/j.colsurfb.2025.115204_bib156","first-page":"1473","article-title":"Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression","volume":"47","author":"Nicolson","year":"1987","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.colsurfb.2025.115204_bib157","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/1567201811666140822112516","article-title":"Nanomedicines based drug delivery systems for anti-cancer targeting and treatment","volume":"12","author":"Jain","year":"2015","journal-title":"Curr. Drug Deliv."},{"issue":"3","key":"10.1016\/j.colsurfb.2025.115204_bib158","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2217\/imt.11.5","article-title":"Antibody-targeted nanoparticles for cancer therapy","volume":"3","author":"Fay","year":"2011","journal-title":"Immunotherapy"},{"issue":"28","key":"10.1016\/j.colsurfb.2025.115204_bib159","doi-asserted-by":"crossref","first-page":"12008","DOI":"10.1039\/D3NR01571H","article-title":"Super-resolution imaging of antibody-conjugated biodegradable periodic mesoporous organosilica nanoparticles for targeted chemotherapy of prostate cancer","volume":"15","author":"Das","year":"2023","journal-title":"Nanoscale"},{"key":"10.1016\/j.colsurfb.2025.115204_bib160","unstructured":"S. Ravella, Navigating the Future of Cancer Diagnosis: A Comprehensive Review of Novel Approaches for Community-Based Treatment. future. 1: p. 6.."},{"issue":"6","key":"10.1016\/j.colsurfb.2025.115204_bib161","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3390\/biomedicines9060635","article-title":"Molecular perspective of nanoparticle mediated therapeutic targeting in breast cancer: an odyssey of endoplasmic reticulum unfolded protein response (UPRER) and beyond","volume":"9","author":"Rahman","year":"2021","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.colsurfb.2025.115204_bib162","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/ilar.46.3.269","article-title":"Critical steps in the production of polyclonal and monoclonal antibodies: evaluation and recommendations","volume":"46","author":"Leenaars","year":"2005","journal-title":"ILAR J."},{"issue":"11","key":"10.1016\/j.colsurfb.2025.115204_bib163","doi-asserted-by":"crossref","first-page":"10636","DOI":"10.1021\/acsnano.8b06104","article-title":"Stimuli-responsive nano-architecture drug-delivery systems to solid tumor micromilieu: past, present, and future perspectives","volume":"12","author":"El-Sawy","year":"2018","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.colsurfb.2025.115204_bib164","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.3390\/ijms18112362","article-title":"ABC transporters in cancer stem cells: beyond chemoresistance","volume":"18","author":"Begicevic","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2025.115204_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109221","article-title":"Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics","volume":"329","author":"Tan","year":"2020","journal-title":"Chem. Biol. Interact."},{"issue":"8","key":"10.1016\/j.colsurfb.2025.115204_bib166","doi-asserted-by":"crossref","first-page":"12567","DOI":"10.1021\/acsnano.1c02103","article-title":"Nanotechnology for boosting cancer immunotherapy and remodeling TME: the horizons in cancer treatment","volume":"15","author":"Gao","year":"2021","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.colsurfb.2025.115204_bib167","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.7150\/thno.11742","article-title":"Current approaches for improving intratumoral accumulation and distribution of nanomedicines","volume":"5","author":"Durymanov","year":"2015","journal-title":"Theranostics"},{"issue":"8-9","key":"10.1016\/j.colsurfb.2025.115204_bib168","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.progpolymsci.2007.05.007","article-title":"Polymer systems for gene delivery\u2014past, present, and future","volume":"32","author":"Wong","year":"2007","journal-title":"Prog. Polym. Sci."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib169","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12951-022-01605-4","article-title":"Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery","volume":"20","author":"Waheed","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.colsurfb.2025.115204_bib170","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/15583724.2018.1437547","article-title":"Approaches to improve therapeutic efficacy of biodegradable PLA\/PLGA microspheres: a review","volume":"58","author":"Bee","year":"2018","journal-title":"Polym. Rev."},{"issue":"2","key":"10.1016\/j.colsurfb.2025.115204_bib171","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1017\/S0033583505004014","article-title":"Cell-penetrating peptides: small from inception to application","volume":"37","author":"Magzoub","year":"2004","journal-title":"Q. Rev. Biophys."},{"issue":"2","key":"10.1016\/j.colsurfb.2025.115204_bib172","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1021\/acs.molpharmaceut.2c00629","article-title":"The recent advance of cell-penetrating and tumor-targeting peptides as drug delivery systems based on TME","volume":"20","author":"Zhang","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2025.115204_bib173","series-title":"Natural polymer drug delivery systems: Nanoparticles, plants, and algae","first-page":"33","article-title":"Nanoparticles types, classification, characterization, fabrication methods and drug delivery applications","author":"Bhatia","year":"2016"},{"issue":"2","key":"10.1016\/j.colsurfb.2025.115204_bib174","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2174\/0929867327666200130101605","article-title":"Nanoparticles in combating cancer: opportunities and limitations: a brief review","volume":"28","author":"Pedziwiatr-Werbicka","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"6","key":"10.1016\/j.colsurfb.2025.115204_bib175","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1083\/jcb.200910104","article-title":"Targeting of drugs and nanoparticles to tumors","volume":"188","author":"Ruoslahti","year":"2010","journal-title":"J. Cell Biol."},{"issue":"15","key":"10.1016\/j.colsurfb.2025.115204_bib176","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.3390\/cancers15153836","article-title":"Cancer bioenergetics and TMEs\u2014Enhancing chemotherapeutics and targeting resistant niches through nanosystems","volume":"15","author":"Farhana","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.colsurfb.2025.115204_bib177","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ceb.2016.05.002","article-title":"Stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ECM interactions","volume":"42","author":"Alexander","year":"2016","journal-title":"Curr. Opin. Cell Biol."},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115204_bib178","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1021\/acs.molpharmaceut.0c00014","article-title":"Emerging nano drug delivery systems targeting cancer-associated fibroblasts for improved antitumor effect and tumor drug penetration","volume":"17","author":"Guo","year":"2020","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.colsurfb.2025.115204_bib179","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/(SICI)1097-0282(1997)43:5<339::AID-BIP2>3.0.CO;2-W","article-title":"Growth factor receptors: structure, mechanism, and drug discovery","volume":"43","author":"McInnes","year":"1997","journal-title":"Pept. Sci."},{"key":"10.1016\/j.colsurfb.2025.115204_bib180","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.856974","article-title":"Breast cancer stem-like cells in drug resistance: a review of mechanisms and novel therapeutic strategies to overcome drug resistance","volume":"12","author":"Saha","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.colsurfb.2025.115204_bib181","article-title":"Discovery and prediction capabilities in metal-based nanomaterials: an overview of the application of machine learning techniques and some recent advances","volume":"52","author":"Bamidele","year":"2022","journal-title":"Adv. Eng. Inform."},{"issue":"29","key":"10.1016\/j.colsurfb.2025.115204_bib182","doi-asserted-by":"crossref","first-page":"13718","DOI":"10.1039\/D4NR01536C","article-title":"Nature-inspired protein mineralization strategies for nanoparticle construction: advancing effective cancer therapy","volume":"16","author":"Cao","year":"2024","journal-title":"Nanoscale"},{"issue":"6","key":"10.1016\/j.colsurfb.2025.115204_bib183","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/00914037.2017.1332623","article-title":"Overview of preparation methods of polymeric and lipid-based (niosome, solid lipid, liposome) nanoparticles: a comprehensive review","volume":"67","author":"Amoabediny","year":"2018","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"key":"10.1016\/j.colsurfb.2025.115204_bib184","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor angiogenesis: causes, consequences, challenges and opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.colsurfb.2025.115204_bib185","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1039\/C5CS00798D","article-title":"Smart micro\/nanoparticles in stimulus-responsive drug\/gene delivery systems","volume":"45","author":"Karimi","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.colsurfb.2025.115204_bib186","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-021-01037-6","article-title":"Molecularly engineered carrier-free co-delivery nanoassembly for self-sensitized photothermal cancer therapy","volume":"19","author":"Shan","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"31","key":"10.1016\/j.colsurfb.2025.115204_bib187","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.2174\/138161282131151013190112","article-title":"Exosomes: natural carriers for siRNA delivery","volume":"21","author":"Kumar","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.colsurfb.2025.115204_bib188","doi-asserted-by":"crossref","first-page":"9355","DOI":"10.2147\/IJN.S281890","article-title":"Advances in exosome-based drug delivery and tumor targeting: from tissue distribution to intracellular fate","author":"Shao","year":"2020","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib189","first-page":"108","article-title":"Exosomes as new vesicular lipid transporters involved in cell\u2013cell communication and various pathophysiologies","volume":"1841","author":"Record","year":"2014","journal-title":"Biochim. et Biophysica Acta (BBA)Mol. Cell Bio. Lipids"},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib190","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12943-019-0975-5","article-title":"Exosomes in the TME as mediators of cancer therapy resistance","volume":"18","author":"Li","year":"2019","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.colsurfb.2025.115204_bib191","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3390\/pharmaceutics15051439","article-title":"Therapeutic and diagnostic potential of exosomes as drug delivery systems in brain cancer","volume":"15","author":"Avgoulas","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib192","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13046-025-03288-9","article-title":"GC-derived exosomal circMAN1A2 promotes cancer progression and suppresses T-cell antitumour immunity by inhibiting FBXW11-mediated SFPQ degradation","volume":"44","author":"Shen","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"15","key":"10.1016\/j.colsurfb.2025.115204_bib193","doi-asserted-by":"crossref","first-page":"7740","DOI":"10.1021\/cr400295a","article-title":"Chemical basis of interactions between engineered nanoparticles and biological systems","volume":"114","author":"Mu","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.colsurfb.2025.115204_bib194","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2015.10.019","article-title":"Combo\u201d nanomedicine: co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy","volume":"98","author":"Kemp","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.colsurfb.2025.115204_bib195","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.3390\/antiox10111801","article-title":"Tumour microenvironment stress promotes the development of drug resistance","volume":"10","author":"Seebacher","year":"2021","journal-title":"Antioxidants"},{"issue":"11","key":"10.1016\/j.colsurfb.2025.115204_bib196","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1021\/cr300068p","article-title":"Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications","volume":"112","author":"Reddy","year":"2012","journal-title":"Chem. Rev."},{"issue":"6","key":"10.1016\/j.colsurfb.2025.115204_bib197","doi-asserted-by":"crossref","first-page":"e1730","DOI":"10.1002\/wnan.1730","article-title":"Remodeling TME with nanomedicines","volume":"13","author":"Martin","year":"2021","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2025.115204_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2022.100051","article-title":"Cancer nanomedicine: a step towards improving the drug delivery and enhanced efficacy of chemotherapeutic drugs","volume":"7","author":"Ahmed","year":"2022","journal-title":"OpenNano"},{"issue":"5","key":"10.1016\/j.colsurfb.2025.115204_bib199","doi-asserted-by":"crossref","first-page":"e1704","DOI":"10.1002\/wnan.1704","article-title":"Combined cancer therapeutics\u2014Tackling the complexity of the TME","volume":"13","author":"Roma-Rodrigues","year":"2021","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2025.115204_bib200","series-title":"in Personalized and Precision Nanomedicine for Cancer Treatment","first-page":"27","article-title":"Cancer stem cells as promising nanotherapeutic targets","author":"Mir","year":"2024"},{"issue":"13","key":"10.1016\/j.colsurfb.2025.115204_bib201","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.3390\/molecules28135145","article-title":"Cancer nanomedicine: emerging strategies and therapeutic potentials","volume":"28","author":"Xu","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.colsurfb.2025.115204_bib202","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2024.07.023","article-title":"Enhancing pancreatic cancer immunotherapy: leveraging localized delivery strategies through the use of implantable devices and scaffolds","volume":"373","author":"Minaei","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2025.115204_bib203","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.nantod.2017.06.010","article-title":"Design of nanocarriers based on complex biological barriers in vivo for tumor therapy","volume":"15","author":"Liu","year":"2017","journal-title":"Nano Today"},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib204","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/molecules20010249","article-title":"Eliminating the heart from the curcumin molecule: monocarbonyl curcumin mimics (MACs)","volume":"20","author":"Shetty","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.colsurfb.2025.115204_bib205","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0065-230X(06)96008-4","article-title":"Pharmacodynamic biomarkers for molecular cancer therapeutics","volume":"96","author":"Sarker","year":"2006","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.colsurfb.2025.115204_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114319","article-title":"Targeting the tumor biophysical microenvironment to reduce resistance to immunotherapy","volume":"186","author":"Zhang","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib207","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1208\/s12248-023-00881-8","article-title":"A bispecific modeling framework enables the prediction of efficacy, toxicity, and optimal molecular design of bispecific antibodies targeting MerTK","volume":"26","author":"Li","year":"2024","journal-title":"AAPS J."},{"issue":"16","key":"10.1016\/j.colsurfb.2025.115204_bib208","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2174\/0113892010275850240102105033","article-title":"Recent advances in pharmaceutical design: unleashing the potential of novel therapeutics","volume":"25","author":"Prajapati","year":"2024","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"1054","key":"10.1016\/j.colsurfb.2025.115204_bib209","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150256","article-title":"Prostate cancer radiotherapy: potential applications of metal nanoparticles for imaging and therapy","volume":"88","author":"Coulter","year":"2015","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.colsurfb.2025.115204_bib210","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.612659","article-title":"Novel methods and approaches for safety evaluation of nanoparticle formulations: a focus towards in vitro models and adverse outcome pathways","volume":"12","author":"Tirumala","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib211","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/nyas.12403","article-title":"Nanomedicines: addressing the scientific and regulatory gap","volume":"1313","author":"Tinkle","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"12","key":"10.1016\/j.colsurfb.2025.115204_bib212","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.3390\/nano11123330","article-title":"Novel perspectives towards RNA-based nano-theranostic approaches for cancer management","volume":"11","author":"Arshad","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.colsurfb.2025.115204_bib213","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.2147\/IJN.S378074","article-title":"Nanotechnology: a promising approach for cancer diagnosis, therapeutics and theragnosis","volume":"17","author":"Dessale","year":"2022","journal-title":"Int. J. Nanomed."},{"issue":"7","key":"10.1016\/j.colsurfb.2025.115204_bib214","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.aos.2011.07.006","article-title":"Tracing performance in the pharmaceutical industry: ambivalence, opacity and the performativity of flawed measures","volume":"36","author":"Dambrin","year":"2011","journal-title":"Account. Organ. Soc."},{"issue":"2","key":"10.1016\/j.colsurfb.2025.115204_bib215","first-page":"107","article-title":"Blueprint for cancer research: critical gaps and opportunities","volume":"71","author":"Elmore","year":"2021","journal-title":"CA A Cancer Journal Clinicians"},{"key":"10.1016\/j.colsurfb.2025.115204_bib216","doi-asserted-by":"crossref","first-page":"8483","DOI":"10.2147\/IJN.S148359","article-title":"Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy","author":"Zhang","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2025.115204_bib217","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2019.11.002","article-title":"Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy","author":"Raj","year":"2021","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115204_bib218","doi-asserted-by":"crossref","first-page":"e1527","DOI":"10.1002\/wnan.1527","article-title":"Stimuli-responsive nanotherapeutics for precision drug delivery and cancer therapy","volume":"11","author":"Qiao","year":"2019","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2025.115204_bib219","doi-asserted-by":"crossref","first-page":"5811","DOI":"10.2147\/IJN.S321416","article-title":"Nanoparticle-mediated targeted drug delivery to remodel TME for cancer therapy","author":"Tang","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2025.115204_bib220","article-title":"Revolutionizing cancer immunotherapy: emerging Nanotechnology-Driven drug delivery systems for enhanced therapeutic efficacy","author":"Theivendren","year":"2024","journal-title":"ACS Meas. Sci. Au"},{"key":"10.1016\/j.colsurfb.2025.115204_bib221","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12672-024-01195-7","article-title":"Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy","volume":"15","author":"Joshi","year":"2024","journal-title":"Discov. Oncol."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776525007118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776525007118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T21:18:38Z","timestamp":1765055918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776525007118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":221,"alternative-id":["S0927776525007118"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.115204","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revolutionizing cancer treatment: Nanotherapeutics targeting the tumor micro-environment","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.115204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115204"}}